Buy Glenmark Pharma, GAIL: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "We have Glenmark Pharma as the buy in pharmaceutical space. Pharmaceuticals as a sector have been buoyant and cheerful. It has been outperforming, Glenmark itself is an outperformer. The stock has been rallying and is in a bull market of its own. So, bull market stocks continue to move up. We would really want to time the entry, this is a good time to buy."
 
"For the last four, five days the share is in a consolidation. Normally, up trending stocks will breakout after the consolidation that is what should happen next week. So, we are buying almost at the point of a breakout. Glenmark is a short-term swing trade on the long side for this reason," Sukhani said.

"GAIL India has seen in bad times. It now appears as this stock is consolidating at lower levels, is making a bullish pattern and is willing to go higher. It is already seen gains this week and the chances are that these gains will be built upon in the next week because once momentum starts on the upside it doesn't vain quickly, it continues till it distributes. So, GAIL is far away from distribution so far. It is a buying opportunity again," he added. Also Read: Glenmark's ANDAs for epilepsy in US face legal challenge